INS and type 1 diabetes mellitus: Decreased blood glucose levels and also reduction of glucose excursion after meals were observed in recent−onset type 1 diabetic patients treated with intravenous or subcutaneous GLP−1 with concurrent administration of multiple dose insulin therapy.